We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRKS:NYSEUnited Parks & Resorts Inc. Analysis

Data as of 2026-06-18 - not real-time

$47.48

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

United Parks & Resorts (PRKS) is trading at $47.48, comfortably above its 20‑day and 50‑day SMAs of $41.96 and $38.18, indicating a short‑term uptrend. However, the RSI of 71 places the stock in overbought territory, warning of a potential pullback. The MACD remains bullish with the line above the signal, but the modest histogram suggests limited momentum. Volatility is elevated at over 50% on a 30‑day basis and beta exceeds 1.4, underscoring heightened price swings. Recent earnings disclosed a widening loss of $34 million and a 3% revenue decline driven by adverse weather and weaker international visitation. Despite the loss, operating cash flow remains positive at $421 million, and free cash flow is modestly positive, providing a cushion for ongoing operations.
Analyst consensus is a “Buy” with a mean target of $44.5, yet the current price sits near the upper resistance level of $48.5, limiting upside in the near term. The company carries a substantial debt load of $2.39 billion and a negative book value per share, which weakens the balance sheet. No dividend is paid, and the price‑to‑book ratio is negative, confirming that income generation, not yield, drives valuation. The consumer‑cyclical leisure sector is sensitive to discretionary spending and weather, adding sector‑specific risk. Given the blend of bullish technical signals, earnings weakness, and high volatility, the stock appears fairly priced but vulnerable to a correction. Investors should monitor attendance trends, weather patterns, and any debt‑restructuring moves before committing additional capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • overbought RSI
  • proximity to resistance
  • high volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • positive operating cash flow
  • bullish MACD
  • analyst buy consensus

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • seasonal weather risk
  • high debt load
  • cyclical consumer demand

Key Metrics & Analysis

Financial Health

Revenue Growth-3.00%
Profit Margin9.10%
P/E Ratio17.8
ROA8.71%
P/B Ratio-4.1
Op. Cash Flow$421.2M
Free Cash Flow$102.6M

Technical Analysis

TrendNeutral
RSI71.5
Support$33.34
Resistance$48.51
MA 20$41.96
MA 50$38.18
MA 200$39.54
MACDBullish
VolumeStable
Fear & Greed Index91.43

Valuation

Target Price$44.50
Upside/Downside-6.28%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.46
Volatility51.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.